DIONNE HOLT: Open Payments
NPI 1477951440 · MOUNTAINSIDE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 50 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,285
Food & beverage: $1,285
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $389 |
| ABBVIE INC. | 16 | $192 |
| Teva Pharmaceuticals USA, Inc. | 6 | $189 |
| Axsome Therapeutics, Inc. | 4 | $165 |
| Neurocrine BioSciences, Inc. | 3 | $155 |
| Alkermes, Inc. | 4 | $76 |
| Almatica Pharma LLC | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, Auvelity, INGREZZA, ARISTADA, LOREEV XR, REXULTI.
Industry payments across NJ — which companies pay providers there.
